Pfizer today announced a partnership with IDA Foundation, an independent social enterprise providing essential medicines to low-and middle-income countries, to provide […]
Germany-based CureVac, the global biopharmaceutical company developing novel transformative medicines based on messenger ribonucleic acid (“mRNA), including a high potential […]
Harvard University’s Wyss Institute for Biologically Inspired Engineering has established its first research and innovation alliance by joining forces with […]
Indiana University (IU) School of Medicine and Eli Lilly have come together to transform how university research and pharmaceutical companies […]
One of the world’s largest contract research organizations (CROs), PPD, Inc. (Nasdaq:PPD) has aligned with Lupus Therapeutics (LT), an affiliate […]
China-based CanSino Biologics, one of the leads in the COVID-19 vaccine race, inked a deal with Pfizer for one of […]
China-based COVID-19 vaccine developer Sinovac Biotech Ltd. (NASDAQ: SVA) inked a clinical development collaboration agreement with a Brazilian producer of […]
Pfizer, one of the world’s biggest pharmaceutical companies announced a partnership with Mainz, Germany based BioNTech, to co-develop and distribute […]
Harvard and Merck will collaborate on research led by Harvard immunologist Arlene Sharpe seeking to identify new pathways for the […]
MD Anderson Inks a strategic partnership with Poland memorializing an agreement to share new technologies in cancer treatment. The deal […]
